Open Meeting Announcement - MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms - September 13, 2024

Date Posted: August 1, 2024

This article has been published for notice under contract numbers: 02101 (AK), 02201 (ID), 02301(OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).

Noridian Healthcare Solutions will be hosting an Open Public Meeting on September 13, 2024, from 1 p.m. to 3 p.m. CT.

Advance registration is required.

  • Registration deadline to present comments on an LCD will close on September 6, 2024, at 11:59 pm CDT.
  • General Registration deadline to participate by listen-only mode will close on September 12, 2024, at 11:59 pm CDT.

Proposed Local Coverage Determination (LCD) and Local Coverage Article (LCA)

  • MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms DL39927
  • Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms DA59837

View meeting details and register now from the Open Meeting webpage.

Last Updated Aug 01 , 2024